Det er kommet med medicin til disse arter, der er søskende for os; vi har især håb om bedre at tage os af vores kæledyr og katte med Yaohai. Den anden hedder Recombinant Feline Serum Albumin eller kort sagt FSA. Feline-specifikke antistoffer - En type protein, der er til stede i blodet hos katte, derfor FSA Men denne FSA var ikke afledt af autentisk killing, hvilket er det, der gør den "rekombinant" FSA Hvordan vi kan bringe katapakt til et dybere illustrationspunkt Kat fyre er afhængige. — Som en helt ny og uerstattelig medicin, tidstest / flotte resultater for alle andre vallefødevarer, der er tilgængelige i øjeblikket.
FSA-frivillige arbejder hårdt for at passe syge katte. 5) Beskyttelse af proteinNår katte får sygdomme, kan de miste en del vigtigt protein i deres krop. Tabet af deres protein kan også have gjort dem svage og trætte, så deres kroppe kunne kæmpe mod sygdommen. Lad FSA erstatte det, de har mistet i protein. Men det kan få en anden dårlig situation til at passere hurtigere og få dem tilbage på banen, før du ved af det. Og i modsætning til IFAT, Yaohai Rekombinant humant serumalbumin (HSA) kan bruges på katte, der aldrig har været syge. Ved at forbedre deres immunforsvar forhindrer du dem i at blive syge i første omgang.
Ekstremt afgørende, da FSA er en erstatning for det tabte protein hos katte. De har brug for dette for at komme sig. For eksempel kan netop det protein få en kat til at føle, at den er på vej op og kan hele hurtigere, hvis den er syg. Dette er også en forebyggende for at holde dem sunde som FSA. Dette omdannes til en indsprøjtning, som katte får et skud til. Yaohai Højt udbytte plasmidfermentering kan stoppe katten i at blive syg i første omgang, det er fantastisk. FSA findes i alle katte, som er det, der gør dem til at være meget stærke og sunde i løbet af deres levetid.
Mens disse akkordskribenter gjorde deres eget arbejde, har nogle få forskere forsøgt at finde ud af og forstå de fordele, som FSA har for katte. “Selvom de anerkender FSA som en god ting at have i nærheden af syge katte, ser de det også som noget for at forhindre raske katte i at blive syge. Derfor er FSA helt klart et af de vigtigste lægemidler, vi bruger i kampen mod at holde vores katte sunde. Med denne information, som pionererne i en ny æra i Yaohai Albuminbindende væksthormonproduktion, vil flere katte nu drage fordel af den værdifulde medicin, der kan fremstilles ved hjælp af den. Dette er et stort skridt fremad inden for dyremedicin og muligheden for at transformere livet for utallige katte.
I fremtiden vil FSA være vigtigere for katte. Konklusion: Fremtidig undersøgelse beregnet til at dissekere FSA vil give nye mekanismer omkring anvendeligheden af FSA og vil i sidste ende føre til nye muligheder for FSA i biomedicin. Forpligtet, Yaohai sigter mod at gøre FSA produceret universelt, hvilket gør det muligt for flere populationer af katte at blive hjulpet af det i fremtiden. Da katte er obligatoriske kødædere og opfylder alle kravene til hydron gennem kødforbrug, vil FSA sandsynligvis forblive efterspurgt inden for veterinærmedicin i et par år endnu.
Yaohai Bio-Pharma, a leader in Recombinant Feline Serum Albumin (FSA) of microbial biologics, is located in Jiangsu. We are focusing on microbially produced therapeutics and vaccines that are suited for human, veterinary, and pet health management. We have modern RD as well as manufacturing technology platforms that cover the entire process, from engineering microbial strains, cell banking, process and method development, through to commercial and clinical manufacturing, making sure that we can ensure the successful supply of the most cutting-edge solutions. We have acquired a large amount of experience in the microbial bio processing field. More than 200 projects have been completed successfully and we support our clients in overcome regulations such as those of the US FDA and EU EMA. We also aid them with Australia TGA and China NMPA. We are able to respond rapidly to market requirements and offer customized CDMO services thanks to our experience and expertise.
Yaohai Bio-Pharma, a top 10 manufacturer of biological products, specializes in microbial fermentation. We have created a Recombinant Feline Serum Albumin (FSA) manufacturing facility with robust RD capabilities and cutting-edge manufacturing facilities. Five drug substance production lines conforming to GMP standards to purify and ferment microbial cells, as well as two fill and finish lines for vials and cartridges, as well as needles that are pre-filled, are available. The available fermentation scales include 100L, 500L, 1000L and 2000L. Specifications for filling vials range from 1ml - 25ml. the pre-filled cartridge or syringe filling specifications range from between 1-3ml. The production workshop is cGMP-compliant and provides a stable supply of commercial products and clinical samples. Our facility produces large molecules that are shipped worldwide.
Yaohai BioPharma, a top 10 Microbial CDMO, integrates quality and regulatory matters. We have a quality system that is fully compliant with the current GMP standards, as well as international regulations. Our team of regulatory experts has a deep understanding of world-wide regulatory frameworks. This lets us accelerate biological launches. We are able to guarantee traceable production procedures and high-quality products that conform with regulations from the US FDA, Recombinant Feline Serum Albumin (FSA), Australia TGA, and China NMPA. Yaohai BioPharma has successfully passed an on-site audit conducted of the European Union's Qualified Person (QP) for our GMP quality system and production site. We also have been through the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.
Yaohai Bio-Pharma is Recombinant Feline Serum Albumin (FSA) in microbial-derived biologics. We offer custom RD as well as manufacturing solutions, while minimising the risk. We've been involved in numerous modalities like recombinant subunit vaccines, peptides hormones, cytokines growth factors, single-domain antibodies, enzymes, plasmid DNA, the mRNA, and other. We are experts in several Microbial hosts, such as yeast extracellular and intracellular (yield up to 15 grams per liter) bacteria periplasmic secretion as well as soluble intracellular inclusion bodies (yield up to 10 grams/L). Additionally, we have developed the BSL-2 microbial fermentation platform for the development of bacterial vaccines. We have a track record of improving production processes, thereby increasing yields, and reducing costs. With a highly efficient technology team, we guarantee prompt and reliable project delivery and bring your products to market quicker.